Novo Nordisk | NVO - Cost Of Sales

Stock Price
41.19
Daily Change
2.66 6.90%
Monthly
13.32%
Yearly
-33.64%
Q2 Forecast
39.20

Novo Nordisk reported DKK1.95B in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
ANI Pharmaceuticals USD 122.88M 6.86M Dec/2025
Aurora Cannabis CAD 88.61M 30.53M Dec/2025
Bausch Health Companies USD 1.03B 284M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 53.08M 8.3M Dec/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Drreddys Laboratories INR 40.46B 3.64B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Novartis USD 3.54B 3M Dec/2025
Novo Nordisk DKK 15.15B 2.3B Dec/2025
Novo Nordisk DKK 1.95B 10.94B Jun/2025
Pacira USD 54.62M 6.02M Dec/2025
Perrigo USD 747.4M 81.2M Dec/2025
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 131.22M 3.52M Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
Zoetis USD 743M 60M Dec/2025